Table of Content

1 Sustained Release Injectables Market Overview
1.1 Product Overview and Scope of Sustained Release Injectables
1.2 Sustained Release Injectables Segment by Type
1.2.1 Global Sustained Release Injectables Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Naltrexone
1.2.3 Exenatide
1.2.4 Estradiol
1.2.5 Other
1.3 Sustained Release Injectables Segment by Application
1.3.1 Sustained Release Injectables Sales Comparison by Application: (2021-2027)
1.3.2 Diabetes
1.3.3 Leukemia
1.3.4 Acromegaly
1.3.5 Other
1.4 Global Sustained Release Injectables Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Injectables Revenue 2016-2027
1.4.2 Global Sustained Release Injectables Sales 2016-2027
1.4.3 Sustained Release Injectables Market Size by Region: 2016 Versus 2021 Versus 2027

2 Sustained Release Injectables Market Competition by Manufacturers
2.1 Global Sustained Release Injectables Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sustained Release Injectables Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sustained Release Injectables Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sustained Release Injectables Manufacturing Sites, Area Served, Product Type
2.5 Sustained Release Injectables Market Competitive Situation and Trends
2.5.1 Sustained Release Injectables Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sustained Release Injectables Players Market Share by Revenue
2.5.3 Global Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Sustained Release Injectables Retrospective Market Scenario by Region
3.1 Global Sustained Release Injectables Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sustained Release Injectables Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sustained Release Injectables Market Facts & Figures by Country
3.3.1 North America Sustained Release Injectables Sales by Country
3.3.2 North America Sustained Release Injectables Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sustained Release Injectables Market Facts & Figures by Country
3.4.1 Europe Sustained Release Injectables Sales by Country
3.4.2 Europe Sustained Release Injectables Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sustained Release Injectables Market Facts & Figures by Region
3.5.1 Asia Pacific Sustained Release Injectables Sales by Region
3.5.2 Asia Pacific Sustained Release Injectables Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sustained Release Injectables Market Facts & Figures by Country
3.6.1 Latin America Sustained Release Injectables Sales by Country
3.6.2 Latin America Sustained Release Injectables Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sustained Release Injectables Market Facts & Figures by Country
3.7.1 Middle East and Africa Sustained Release Injectables Sales by Country
3.7.2 Middle East and Africa Sustained Release Injectables Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sustained Release Injectables Historic Market Analysis by Type
4.1 Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
4.2 Global Sustained Release Injectables Revenue Market Share by Type (2016-2021)
4.3 Global Sustained Release Injectables Price by Type (2016-2021)

5 Global Sustained Release Injectables Historic Market Analysis by Application
5.1 Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
5.2 Global Sustained Release Injectables Revenue Market Share by Application (2016-2021)
5.3 Global Sustained Release Injectables Price by Application (2016-2021)

6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AstraZeneca Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eli Lilly Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aurobindo Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Avadel
6.6.1 Avadel Corporation Information
6.6.2 Avadel Description and Business Overview
6.6.3 Avadel Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Avadel Product Portfolio
6.7.5 Avadel Recent Developments/Updates
6.8 Biomarin
6.8.1 Biomarin Corporation Information
6.8.2 Biomarin Description and Business Overview
6.8.3 Biomarin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biomarin Product Portfolio
6.8.5 Biomarin Recent Developments/Updates
6.9 Camurus
6.9.1 Camurus Corporation Information
6.9.2 Camurus Description and Business Overview
6.9.3 Camurus Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Camurus Product Portfolio
6.9.5 Camurus Recent Developments/Updates
6.10 Critical Pharmaceuticals
6.10.1 Critical Pharmaceuticals Corporation Information
6.10.2 Critical Pharmaceuticals Description and Business Overview
6.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Critical Pharmaceuticals Product Portfolio
6.10.5 Critical Pharmaceuticals Recent Developments/Updates
6.11 Alkermes
6.11.1 Alkermes Corporation Information
6.11.2 Alkermes Sustained Release Injectables Description and Business Overview
6.11.3 Alkermes Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Alkermes Product Portfolio
6.11.5 Alkermes Recent Developments/Updates
6.12 Amylin
6.12.1 Amylin Corporation Information
6.12.2 Amylin Sustained Release Injectables Description and Business Overview
6.12.3 Amylin Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Amylin Product Portfolio
6.12.5 Amylin Recent Developments/Updates
6.13 Ascendis Pharma
6.13.1 Ascendis Pharma Corporation Information
6.13.2 Ascendis Pharma Sustained Release Injectables Description and Business Overview
6.13.3 Ascendis Pharma Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ascendis Pharma Product Portfolio
6.13.5 Ascendis Pharma Recent Developments/Updates
6.14 Taiwan Liposome Company
6.14.1 Taiwan Liposome Company Corporation Information
6.14.2 Taiwan Liposome Company Sustained Release Injectables Description and Business Overview
6.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Taiwan Liposome Company Product Portfolio
6.14.5 Taiwan Liposome Company Recent Developments/Updates

7 Sustained Release Injectables Manufacturing Cost Analysis
7.1 Sustained Release Injectables Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sustained Release Injectables
7.4 Sustained Release Injectables Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sustained Release Injectables Distributors List
8.3 Sustained Release Injectables Customers

9 Sustained Release Injectables Market Dynamics
9.1 Sustained Release Injectables Industry Trends
9.2 Sustained Release Injectables Growth Drivers
9.3 Sustained Release Injectables Market Challenges
9.4 Sustained Release Injectables Market Restraints

10 Global Market Forecast
10.1 Sustained Release Injectables Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sustained Release Injectables by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sustained Release Injectables by Type (2022-2027)
10.2 Sustained Release Injectables Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sustained Release Injectables by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sustained Release Injectables by Application (2022-2027)
10.3 Sustained Release Injectables Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sustained Release Injectables by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sustained Release Injectables by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Sustained Release Injectables Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sustained Release Injectables Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Sustained Release Injectables Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sustained Release Injectables Covered in This Study
Table 5. Global Sustained Release Injectables Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Sustained Release Injectables Sales Share by Manufacturers (2016-2021)
Table 7. Global Sustained Release Injectables Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sustained Release Injectables Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sustained Release Injectables Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sustained Release Injectables Manufacturing Sites and Area Served
Table 11. Manufacturers Sustained Release Injectables Product Type
Table 12. Global Sustained Release Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sustained Release Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Injectables as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sustained Release Injectables Sales by Region (2016-2021) & (K Units)
Table 16. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
Table 17. Global Sustained Release Injectables Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 19. North America Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 20. North America Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 22. Europe Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 23. Europe Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 24. Europe Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sustained Release Injectables Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Sustained Release Injectables Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sustained Release Injectables Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sustained Release Injectables Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 32. Latin America Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sustained Release Injectables Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Sustained Release Injectables Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sustained Release Injectables Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sustained Release Injectables Revenue Market Share by Country (2016-2021)
Table 38. Global Sustained Release Injectables Sales (K Units) by Type (2016-2021)
Table 39. Global Sustained Release Injectables Sales Market Share by Type (2016-2021)
Table 40. Global Sustained Release Injectables Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sustained Release Injectables Revenue Share by Type (2016-2021)
Table 42. Global Sustained Release Injectables Price (USD/Unit) by Type (2016-2021)
Table 43. Global Sustained Release Injectables Sales (K Units) by Application (2016-2021)
Table 44. Global Sustained Release Injectables Sales Market Share by Application (2016-2021)
Table 45. Global Sustained Release Injectables Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sustained Release Injectables Revenue Share by Application (2016-2021)
Table 47. Global Sustained Release Injectables Price (USD/Unit) by Application (2016-2021)
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Business Overview
Table 50. AstraZeneca Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. AstraZeneca Sustained Release Injectables Product
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Eli Lilly Corporation Information
Table 54. Eli Lilly Description and Business Overview
Table 55. Eli Lilly Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Eli Lilly Sustained Release Injectables Product
Table 57. Eli Lilly Recent Developments/Updates
Table 58. Sanofi Corporation Information
Table 59. Sanofi Description and Business Overview
Table 60. Sanofi Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Sanofi Sustained Release Injectables Product
Table 62. Sanofi Recent Developments/Updates
Table 63. Roche Corporation Information
Table 64. Roche Description and Business Overview
Table 65. Roche Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Roche Sustained Release Injectables Product
Table 67. Roche Recent Developments/Updates
Table 68. Novartis Corporation Information
Table 69. Novartis Description and Business Overview
Table 70. Novartis Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Novartis Sustained Release Injectables Product
Table 72. Novartis Recent Developments/Updates
Table 73. Aurobindo Corporation Information
Table 74. Aurobindo Description and Business Overview
Table 75. Aurobindo Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Aurobindo Sustained Release Injectables Product
Table 77. Aurobindo Recent Developments/Updates
Table 78. Avadel Corporation Information
Table 79. Avadel Description and Business Overview
Table 80. Avadel Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Avadel Sustained Release Injectables Product
Table 82. Avadel Recent Developments/Updates
Table 83. Biomarin Corporation Information
Table 84. Biomarin Description and Business Overview
Table 85. Biomarin Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Biomarin Sustained Release Injectables Product
Table 87. Biomarin Recent Developments/Updates
Table 88. Camurus Corporation Information
Table 89. Camurus Description and Business Overview
Table 90. Camurus Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Camurus Sustained Release Injectables Product
Table 92. Camurus Recent Developments/Updates
Table 93. Critical Pharmaceuticals Corporation Information
Table 94. Critical Pharmaceuticals Description and Business Overview
Table 95. Critical Pharmaceuticals Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Critical Pharmaceuticals Sustained Release Injectables Product
Table 97. Critical Pharmaceuticals Recent Developments/Updates
Table 98. Alkermes Corporation Information
Table 99. Alkermes Description and Business Overview
Table 100. Alkermes Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Alkermes Sustained Release Injectables Product
Table 102. Alkermes Recent Developments/Updates
Table 103. Amylin Corporation Information
Table 104. Amylin Description and Business Overview
Table 105. Amylin Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Amylin Sustained Release Injectables Product
Table 107. Amylin Recent Developments/Updates
Table 108. Ascendis Pharma Corporation Information
Table 109. Ascendis Pharma Description and Business Overview
Table 110. Ascendis Pharma Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Ascendis Pharma Sustained Release Injectables Product
Table 112. Ascendis Pharma Recent Developments/Updates
Table 113. Taiwan Liposome Company Corporation Information
Table 114. Taiwan Liposome Company Description and Business Overview
Table 115. Taiwan Liposome Company Sustained Release Injectables Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Taiwan Liposome Company Sustained Release Injectables Product
Table 117. Taiwan Liposome Company Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Sustained Release Injectables Distributors List
Table 121. Sustained Release Injectables Customers List
Table 122. Sustained Release Injectables Market Trends
Table 123. Sustained Release Injectables Growth Drivers
Table 124. Sustained Release Injectables Market Restraints
Table 125. Global Sustained Release Injectables Sales Forecast by Type (2022-2027) & (K Units)
Table 126. Global Sustained Release Injectables Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Sustained Release Injectables Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Sustained Release Injectables Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Sustained Release Injectables Sales Forecast by Application (2022-2027) & (K Units)
Table 130. Global Sustained Release Injectables Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Sustained Release Injectables Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Sustained Release Injectables Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Sustained Release Injectables Sales Forecast by Region (2022-2027) & (K Units)
Table 134. Global Sustained Release Injectables Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Sustained Release Injectables Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Sustained Release Injectables Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained Release Injectables
Figure 2. Global Sustained Release Injectables Market Share by Type in 2020 & 2027
Figure 3. Naltrexone Product Picture
Figure 4. Exenatide Product Picture
Figure 5. Estradiol Product Picture
Figure 6. Other Product Picture
Figure 7. Global Sustained Release Injectables Market Share by Application in 2020 & 2027
Figure 8. Diabetes
Figure 9. Leukemia
Figure 10. Acromegaly
Figure 11. Other
Figure 12. Global Sustained Release Injectables Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sustained Release Injectables Market Size 2016-2027 (US$ Million)
Figure 14. Global Sustained Release Injectables Sales 2016-2027 (K Units)
Figure 15. Global Sustained Release Injectables Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Sustained Release Injectables Sales Share by Manufacturers in 2020
Figure 17. Global Sustained Release Injectables Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Sustained Release Injectables Players: Market Share by Revenue in 2020
Figure 19. Sustained Release Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Sustained Release Injectables Sales Market Share by Region (2016-2021)
Figure 21. Global Sustained Release Injectables Sales Market Share by Region in 2020
Figure 22. Global Sustained Release Injectables Revenue Market Share by Region (2016-2021)
Figure 23. Global Sustained Release Injectables Revenue Market Share by Region in 2020
Figure 24. U.S. Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Sustained Release Injectables Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Sustained Release Injectables by Type (2016-2021)
Figure 49. Sales Market Share of Sustained Release Injectables by Application (2016-2021)
Figure 50. Sales Market Share of Sustained Release Injectables by Application in 2020
Figure 51. Revenue Share of Sustained Release Injectables by Application (2016-2021)
Figure 52. Revenue Share of Sustained Release Injectables by Application in 2020
Figure 53. Manufacturing Cost Structure of Sustained Release Injectables
Figure 54. Manufacturing Process Analysis of Sustained Release Injectables
Figure 55. Sustained Release Injectables Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed